Spinal cord pathology in alpha-synuclein transgenic mice
about
M1 and M2 immune activation in Parkinson's Disease: Foe and ally?Progressive neurodegeneration or endogenous compensation in an animal model of Parkinson's disease produced by decreasing doses of alpha-synuclein.Olfaction in three genetic and two MPTP-induced Parkinson's disease mouse models.BPOZ-2 Gene Delivery Ameliorates Alpha-Synucleinopathy in A53T Transgenic Mouse Model of Parkinson's DiseaseTracking extranigral degeneration in animal models of Parkinson's disease: quest for effective therapeutic strategies.
P2860
Spinal cord pathology in alpha-synuclein transgenic mice
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Spinal cord pathology in alpha-synuclein transgenic mice
@ast
Spinal cord pathology in alpha-synuclein transgenic mice
@en
Spinal cord pathology in alpha-synuclein transgenic mice
@nl
type
label
Spinal cord pathology in alpha-synuclein transgenic mice
@ast
Spinal cord pathology in alpha-synuclein transgenic mice
@en
Spinal cord pathology in alpha-synuclein transgenic mice
@nl
prefLabel
Spinal cord pathology in alpha-synuclein transgenic mice
@ast
Spinal cord pathology in alpha-synuclein transgenic mice
@en
Spinal cord pathology in alpha-synuclein transgenic mice
@nl
P2093
P2860
P356
P1433
P1476
Spinal cord pathology in alpha-synuclein transgenic mice
@en
P2093
Daniel Segelcke
Hermann Lübbert
Saskia Schmidt
Sonja Mendritzki
Teresa Sczepan
P2860
P304
P356
10.4061/2010/375462
P50
P577
2010-07-08T00:00:00Z